ZA939566B - Method for dry blend compression od medicaments. - Google Patents

Method for dry blend compression od medicaments.

Info

Publication number
ZA939566B
ZA939566B ZA939566A ZA939566A ZA939566B ZA 939566 B ZA939566 B ZA 939566B ZA 939566 A ZA939566 A ZA 939566A ZA 939566 A ZA939566 A ZA 939566A ZA 939566 B ZA939566 B ZA 939566B
Authority
ZA
South Africa
Prior art keywords
dry blend
agglomerated
medicaments
excipients
disclosed
Prior art date
Application number
ZA939566A
Other languages
English (en)
Inventor
Frank C Greaves
James Swarbick
Martin W Beasley
Original Assignee
Applied Analytical Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Analytical Ind Inc filed Critical Applied Analytical Ind Inc
Priority to ZA939566A priority Critical patent/ZA939566B/xx
Publication of ZA939566B publication Critical patent/ZA939566B/xx
Priority to AU14398/95A priority patent/AU1439895A/en
Priority to JP7517545A priority patent/JPH09506900A/ja
Priority to PCT/US1994/014639 priority patent/WO1995017169A1/en
Priority to AT95906013T priority patent/ATE220539T1/de
Priority to CA002176460A priority patent/CA2176460C/en
Priority to EP95906013A priority patent/EP0735862B1/en
Priority to US08/649,719 priority patent/US5928668A/en
Priority to DE69430996T priority patent/DE69430996T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA939566A 1993-12-21 1993-12-21 Method for dry blend compression od medicaments. ZA939566B (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ZA939566A ZA939566B (en) 1993-12-21 1993-12-21 Method for dry blend compression od medicaments.
AU14398/95A AU1439895A (en) 1993-12-21 1994-12-20 Method for dry blend compression of medicaments
JP7517545A JPH09506900A (ja) 1993-12-21 1994-12-20 薬物の乾燥混和物圧縮法
PCT/US1994/014639 WO1995017169A1 (en) 1993-12-21 1994-12-20 Method for dry blend compression of medicaments
AT95906013T ATE220539T1 (de) 1993-12-21 1994-12-20 Verfahren zur trockenmischungkompression von arzneimitteln
CA002176460A CA2176460C (en) 1993-12-21 1994-12-20 Method for dry blend compression of medicaments
EP95906013A EP0735862B1 (en) 1993-12-21 1994-12-20 Method for dry blend compression of medicaments
US08/649,719 US5928668A (en) 1993-12-21 1994-12-20 Method for dry blend compression of medicaments
DE69430996T DE69430996T2 (de) 1993-12-21 1994-12-20 Verfahren zur trockenmischungkompression von arzneimitteln

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA939566A ZA939566B (en) 1993-12-21 1993-12-21 Method for dry blend compression od medicaments.

Publications (1)

Publication Number Publication Date
ZA939566B true ZA939566B (en) 1994-08-11

Family

ID=25583540

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939566A ZA939566B (en) 1993-12-21 1993-12-21 Method for dry blend compression od medicaments.

Country Status (7)

Country Link
EP (1) EP0735862B1 (xx)
JP (1) JPH09506900A (xx)
AT (1) ATE220539T1 (xx)
AU (1) AU1439895A (xx)
DE (1) DE69430996T2 (xx)
WO (1) WO1995017169A1 (xx)
ZA (1) ZA939566B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997000682A1 (en) * 1995-06-22 1997-01-09 Akzo Nobel N.V. Compressed dry-granulation desogestrel tablets

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996018386A1 (en) * 1994-12-14 1996-06-20 Enbalt Trading Limited Pharmaceutical tablet formulations for direct compression
AU4777896A (en) * 1995-02-10 1996-08-27 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
EP1214076B1 (en) * 1999-08-31 2003-11-19 Schering Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571045B1 (fr) * 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997000682A1 (en) * 1995-06-22 1997-01-09 Akzo Nobel N.V. Compressed dry-granulation desogestrel tablets

Also Published As

Publication number Publication date
EP0735862B1 (en) 2002-07-17
ATE220539T1 (de) 2002-08-15
WO1995017169A1 (en) 1995-06-29
DE69430996D1 (de) 2002-08-22
AU1439895A (en) 1995-07-10
JPH09506900A (ja) 1997-07-08
DE69430996T2 (de) 2003-03-13
EP0735862A1 (en) 1996-10-09

Similar Documents

Publication Publication Date Title
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
WO1995001782A3 (en) Method for making freeze dried drug dosage forms
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
AU1269895A (en) Parathyroid hormone formulation
NO933239L (xx)
LT2000064A (en) Flash-melt oral dosage formulation
EP0875245A3 (en) Substained release polymer blend matrix for pharmaceutical application
AU1211992A (en) Low dose dry pharmaceutical preparations
IL109800A (en) Sustained release drug formulation containing a tramadol salt comprising cellulose ether and/or cellulose ester having a viscosity between 3,000 and 150,000 mPas
CA2152795A1 (en) Readily available konjac glucomannan sustained release excipient
YU48583B (sh) Postupak za pripremanje formulacije u obliku pilule za oralno davanje
EP0619119A4 (en) COMPOSITION BASED ON STABILIZED PARATHYROIDIAN HORMONE.
HU9302971D0 (en) Chewable antacid preparations
CA2283408A1 (en) Swallow tablet comprising paracetamol
WO1994008613A3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
IL115590A0 (en) Pharmaceutical formulation comprising a growth hormone and isoleucine
EP0392487A3 (en) Stabilized composition of anthracyclines
KR900004326A (ko) 디히드로에르고톡신 및 그의 산 부가염의 분산성 정제
ZA939566B (en) Method for dry blend compression od medicaments.
GB9103764D0 (en) Compositions
WO2000072820A3 (en) Injectable anesthetic formulation
NZ234268A (en) Vasoactive intestinal peptide analogues, derivatives and pharmaceutical compositions
CA2502582A1 (en) Pharmaceutical formulation of olanzapine
CA2176460A1 (en) Method for dry blend compression of medicaments